News

Pharmabiz13h
Gain Therapeutics completes enrollment in phase 1b study to evaluate GT-02287 in Parkinson’s disease with or without a GBA1 mutation
Bethesda, Maryland Wednesday, July 2, 2025, 18:00 Hrs [IST] ...
Pharmabiz14h
University of Salford, CSIR-IGIB and ORDI host glaucoma awareness and advocacy workshop
University of Salford, CSIR-IGIB and ORDI host glaucoma awareness and advocacy workshop: Our Bureau, Bengaluru Wednesday, July 2, 2025, 17:15 Hrs [IST] The University of Salford ( ...
Pharmabiz14h
Camurus’ Oczyesa receives European marketing authorization for treatment of acromegaly
Camurus’ Oczyesa receives European marketing authorization for treatment of acromegaly: Lund, Sweden Wednesday, July 2, 2025, 17:00 Hrs [IST] Camurus, an international, science- ...
Pharmabiz15h
Merck announces 2025 Merck Young Scientist Award
Our Bureau, Bengaluru Wednesday, July 2, 2025, 16:15 Hrs [IST] Merck is back with its fourth edition of the Merck Young Scientist ...
Pharmabiz14h
Parexel to strengthen regulatory, medical and AI expertise; appoints Lola Fashoyin-Aje and Tala Fakhouri to its consulting team
Parexel to strengthen regulatory, medical and AI expertise; appoints Lola Fashoyin-Aje and Tala Fakhouri to its consulting team: Our Bureau, Bengaluru Wednesday, July 2, 2025, 16: ...
Pharmabiz16h
AstraZeneca Pharma India gets CDSCO approval for treating endometrial cancer in the country
AstraZeneca Pharma India gets CDSCO approval for treating endometrial cancer in the country: Our Bureau, Bengaluru Wednesday, July 2, 2025, 15:15 Hrs [IST] AstraZeneca Pharma Indi ...
Pharmabiz18h
NIH study shows breast cancer risk in younger women may be influenced by hormone therapy
NIH study shows breast cancer risk in younger women may be influenced by hormone therapy: Bethesda, Maryland Wednesday, July 2, 2025, 13:00 Hrs [IST] Scientists at the National In ...
Pharmabiz17h
Repronovo announces first participant included in US phase 2 trial of RPN-001 to treat MALE INFERTILITY
Repronovo announces first participant included in US phase 2 trial of RPN-001 to treat MALE INFERTILITY: Lausanne, Switzerland Wednesday, July 2, 2025, 14:00 Hrs [IST] ReproNovo, ...
Pharmabiz20h
Lupin receives US FDA approval for loteprednol etabonate ophthalmic gel
Lupin receives US FDA approval for loteprednol etabonate ophthalmic gel: Our Bureau, Mumbai Wednesday, July 2, 2025, 11:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...
Pharmabiz20h
WuXi XDC announces the mechanical completion of its Singapore site, accelerating the global expansion of bioconjugates manufacturing
WuXi XDC announces the mechanical completion of its Singapore site, accelerating the global expansion of bioconjugates manufacturing: Shanghai, China Wednesday, July 2, 2025, 11:0 ...
Pharmabiz15h
Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine
Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine: Cambridge, Massachusetts Wednesday, July 2, 2025, 16:00 Hrs [IST] Moderna, Inc ...
Pharmabiz21h
atai Life Sciences & Beckley Psytech announce positive results from phase 2b study of BPL-003 in patients with treatment-resistant depression
Life Sciences & Beckley Psytech announce positive results from phase 2b study of BPL-003 in patients with treatment-resistant depression: New York Wednesday, July 2, 2025, 10 ...